Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
The Zacks Analyst Blog UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer
09:46am, Thursday, 12'th Oct 2023
UnitedHealth, Chevron, AstraZeneca, Adobe and Pfizer are part of the Zacks Analyst Blog.
Here's Why Astrazeneca (AZN) Gained But Lagged the Market Today
07:32pm, Friday, 06'th Oct 2023
Astrazeneca (AZN) concluded the recent trading session at $67.42, signifying a +0.81% move from its prior day's close.
Nobel for mRNA: Which other biotech stocks might be overlooked?
08:33am, Friday, 06'th Oct 2023
Scientists Katalin Karikó and Drew Weissman were awarded the Nobel prize this week for a discovery that went under the radar for many years, until it was found to hold the key to stabilising mRNA v
2 Nasdaq 100 Stocks That Are Surefire Buys in October, and 1 to Avoid Like the Plague
05:21am, Friday, 06'th Oct 2023
The Nasdaq 100 has been absolutely whipsawed in recent years. Two Nasdaq 100 stocks possess the necessary catalysts to fuel double-digit earnings growth.
AstraZeneca (AZN) Settles Heartburn Drugs Lawsuits for $425M
09:46am, Wednesday, 04'th Oct 2023
AstraZeneca (AZN) agrees to pay $425 million to settle lawsuits related to heartburn drugs, Nexium and Prilosec.
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
09:10am, Tuesday, 03'rd Oct 2023
The payout will settle the claims of 11,000 people who said they weren't property warned Nexium and Prilosec could cause chronic kidney disease.
AstraZeneca settles Nexium heartburn drug cases for US$425m
03:03am, Tuesday, 03'rd Oct 2023
AstraZeneca said it has settled a suite of US legal claims over heartburn treatments Nexium and Prilosec for US$425 million. The UK pharma said the agreements effectively resolve the product liabili
AstraZeneca to pay $425 mln to settle Nexium, Prilosec litigation in US
02:16am, Tuesday, 03'rd Oct 2023
British drugmaker AstraZeneca on Tuesday said it will pay $425 million to settle product liability litigations related to acid-reflux medicine Nexium and heartburn drug Prilosec in the United States.
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
10:20am, Friday, 29'th Sep 2023
Several major drugmakers, including Merck & Co. Inc. MRK and AstraZeneca PLC AZN, say they're moving forward with the Medicare drug-price negotiation process ahead of this Sunday's deadline to sign ag
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
11:18pm, Thursday, 28'th Sep 2023
Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings pote
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
03:55pm, Wednesday, 27'th Sep 2023
AstraZeneca, Boehringer Ingelheim and other drugmakers have filed at least eight lawsuits seeking to declare the Medicare price talks unconstitutional.
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
10:31am, Tuesday, 26'th Sep 2023
Astrazeneca (AZN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
08:00am, Tuesday, 26'th Sep 2023
AstraZeneca is the largest foreign owned pharmaceutical company in China based on revenue, and they're continuing to increase investment in the country
AstraZeneca stock upgraded to Buy at Jefferies
04:24pm, Monday, 25'th Sep 2023
Shares of biopharmaceutical giant AstraZeneca (AZN) were upgraded to "Buy" from "Hold" at Jefferies. The analyst says assets outside of the company's oncology pipeline are being overlooked.
AstraZeneca's (AZN) Dato-DXd Meets Goal in Breast Cancer Study
12:46pm, Monday, 25'th Sep 2023
AstraZeneca (AZN) announces positive results from the late-stage study evaluating its antibody-drug conjugate, Dato-DXd, in pre-treated patients with HR+/HER2- metastatic breast cancer.
